Karen L. Swanson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karen L. Swanson has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Anthony W. Stanson
2 shared publications- Patrick S. Kamath
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
2 shared publications - Preet Paul Singh
Washington University School of Medicine in St. Louis, St. Louis, MO
2 shared publications Amani Elshaer
Resident in Internal Medicine, Mayo Clinic School of Graduate Medical Education, Phoenix, AZ, USA
1 shared publication- Brandon Nokes
VA San Diego Healthcare System
1 shared publication Brandon T. Larsen
The Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, United States
1 shared publication
Latest Publications
- 30 October 2025
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 100 (12) , 2237-2242
32-Year-Old Woman Presenting With Hemoptysis
- 30 October 2025
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 100 (12) , 2237-2242
32-Year-Old Woman Presenting With Hemoptysis
- 20 December 2022
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 30 (4) , 321-327
Feasibility and Efficacy of a Non-Opioid Based Pain Management After Medical Thoracoscopy
Background: Prescription opioids are a major cause of the opioid epidemic. Despite the minimally invasive nature of medical thoracoscopy (MT), data on the efficacy of non-opioid-based pain control after MT is lacking. The purpose of this study is to assess the feasibility and efficacy of a non-opioid-based pain management strategy in patients who underwent MT. Methods: We performed a retrospective analysis of all patients who underwent MT in the Mayo Clinic (Minnesota and Arizona) outpatient setting. We assessed their pain level and the need for analgesia post-MT from August 1, 2019, to May 24, 2021. Results: Forty patients were included. In the first 24 hours, 5/40 (12.5%) reported no pain. Twenty-eight patients out of 40 (70%) reported minor pain (pain scale 1-3), and 7/40 (17.5%) reported moderate pain (pain scale 4-6). No patients reported severe pain. Twenty-two out of 35 patients who experienced discomfort (63%) required acetaminophen, 6/35 patients (17%) required nonsteroidal anti-inflammatory drug, and 7/35 patients (20%) did not require analgesia. Of the 7 patients who had moderate pain, 5 (71%) reported that the moderate pain improved to mild at 72 hours post-MT. Zero patients required opioids, and none reported contacting any provider to manage the pain post-MT. Fourteen patients (78%) who had both parietal pleural biopsies and tunneled pleural catheter placed reported minor pain, 3 patients (17%) reported moderate pain, and 1 patient (6%) experienced no discomfort. Conclusion: MT is well-tolerated by patients with non-opioid-based pain management strategy as needed if there is no absolute contraindication.
- 20 December 2022
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 30 (4) , 321-327
Feasibility and Efficacy of a Non-Opioid Based Pain Management After Medical Thoracoscopy
Background: Prescription opioids are a major cause of the opioid epidemic. Despite the minimally invasive nature of medical thoracoscopy (MT), data on the efficacy of non-opioid-based pain control after MT is lacking. The purpose of this study is to assess the feasibility and efficacy of a non-opioid-based pain management strategy in patients who underwent MT. Methods: We performed a retrospective analysis of all patients who underwent MT in the Mayo Clinic (Minnesota and Arizona) outpatient setting. We assessed their pain level and the need for analgesia post-MT from August 1, 2019, to May 24, 2021. Results: Forty patients were included. In the first 24 hours, 5/40 (12.5%) reported no pain. Twenty-eight patients out of 40 (70%) reported minor pain (pain scale 1-3), and 7/40 (17.5%) reported moderate pain (pain scale 4-6). No patients reported severe pain. Twenty-two out of 35 patients who experienced discomfort (63%) required acetaminophen, 6/35 patients (17%) required nonsteroidal anti-inflammatory drug, and 7/35 patients (20%) did not require analgesia. Of the 7 patients who had moderate pain, 5 (71%) reported that the moderate pain improved to mild at 72 hours post-MT. Zero patients required opioids, and none reported contacting any provider to manage the pain post-MT. Fourteen patients (78%) who had both parietal pleural biopsies and tunneled pleural catheter placed reported minor pain, 3 patients (17%) reported moderate pain, and 1 patient (6%) experienced no discomfort. Conclusion: MT is well-tolerated by patients with non-opioid-based pain management strategy as needed if there is no absolute contraindication.
- 1 March 2022
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 97 (3) , 609-613
58-Year-Old Woman With Cough and Dyspnea
- 1 March 2022
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 97 (3) , 609-613
58-Year-Old Woman With Cough and Dyspnea
- 17 June 2019
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 25 (8) , 1136-1137
Translational Research in Hepatopulmonary Syndrome: Lessons Learned Despite Negative Results
- 17 June 2019
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 25 (8) , 1136-1137
Translational Research in Hepatopulmonary Syndrome: Lessons Learned Despite Negative Results
- Open Access
- 1 January 2017
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 22, 209-211
Intrathoracic ganglioneuroma presenting as an endobronchial mass
- 1 January 2017
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 22, 209-211
Open AccessIntrathoracic ganglioneuroma presenting as an endobronchial mass
- 11 December 2014
- Published by Springer Nature
- p. 201-210
Hepatopulmonary Syndrome
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Sa1017 Clinically Significant Hepatic Involvement in Hereditary Hemorrhagic Telangiectasia (HHT)
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Sa1017 Clinically Significant Hepatic Involvement in Hereditary Hemorrhagic Telangiectasia (HHT)